Zobrazeno 1 - 10
of 78
pro vyhledávání: '"HEE JEONG CHO"'
Autor:
Ji Hyun Lee, Jimin Choi, Chang-Ki Min, Sung-Soo Park, Jae-Cheol Jo, Yoo Jin Lee, Jin Seok Kim, Hyeon-Seok Eom, Jongheon Jung, Joon Ho Moon, Hee Jeong Cho, Myung-won Lee, Sung-Soo Yoon, Ja Min Byun, Jae Hoon Lee, Je-Jung Lee, Sung-Hoon Jung, Ho-Jin Shin, Do Young Kim, Jun Ho Yi, Seung-Shin Lee, Young Rok Do, Dok Hyun Yoon, Hyungwoo Cho, Won Sik Lee, Ho Sup Lee, Jieun Uhm, Hyo Jung Kim, Hee Ryeong Jang, Sung-Hyun Kim, Kihyun Kim
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Carfilzomib, lenalidomide, and dexamethasone (KRd) combination therapy improves the survival of patients with relapsed and/or refractory multiple myeloma (RRMM). Nonetheless, evidence on the use of KRd in Asian populations remains scarce. Accordingly
Externí odkaz:
https://doaj.org/article/064da959c7a04a2988554e9f91efe087
Autor:
Juhyung Kim, Soyoon Hwang, Narae Hwang, Yeonji Lee, Hee Jeong Cho, Joon Ho Moon, Sang Kyun Sohn, Dong Won Baek
Publikováno v:
Journal of Yeungnam Medical Science, Vol 40, Iss 3, Pp 283-288 (2023)
Severe chronic neutropenia is classified as severe congenital, cyclic, autoimmune, or idiopathic. However, there is a lot of uncertainty regarding the diagnosis of severe congenital neutropenia (SCN) and chronic idiopathic neutropenia, and this uncer
Externí odkaz:
https://doaj.org/article/87a976fa16a4488f9fe9d28b21ea1fd5
Autor:
Hyungwoo Cho, Kihyun Kim, Sang Eun Yoon, Sung‐Hoon Jung, Je‐Jung Lee, Joon Ho Moon, Hee Jeong Cho, Ho Sup Lee, Ka‐Won Kang, Sung‐Yong Kim, Hyeon‐Seok Eom, Yeung‐Chul Mun, Young Hoon Park, Sung‐Soo Yoon, Young Rok Do, Won Sik Lee, Chang‐Ki Min, Dok Hyun Yoon
Publikováno v:
HemaSphere, Vol 8, Iss 1, Pp n/a-n/a (2024)
Externí odkaz:
https://doaj.org/article/83f0181575af46f6b195657a752b4626
Autor:
Hee Jeong Cho, Jae-Cheol Jo, Yoo Jin Lee, Myung Won Lee, Do Young Kim, Ho Jin Shin, Sung Nam Im, Ji Hyun Lee, Sung Hwa Bae, Young Rok Do, Won Sik Lee, Min Kyung Kim, Jina Jung, Jung Min Lee, Ju-Hyung Kim, Dong Won Baek, Sang-Kyun Sohn, Joon Ho Moon
Publikováno v:
The Korean Journal of Internal Medicine, Vol 38, Iss 2, Pp 238-247 (2023)
Background/Aims Daratumumab has shown an encouraging antitumor effect in patients with multiple myeloma (MM), and was known to alter the immune properties by off-targeting immunosuppressive cells. Here, we aimed to evaluate the change in absolute lym
Externí odkaz:
https://doaj.org/article/ae24d4e0897248d2a9eeeb9acb663e6d
Publikováno v:
Journal of Yeungnam Medical Science, Vol 39, Iss 4, Pp 300-308 (2022)
Background This study investigated the prognostic impact of spine magnetic resonance imaging (MRI) in patients newly diagnosed with multiple myeloma (MM). Methods We retrospectively evaluated 214 patients who were newly diagnosed with MM between Marc
Externí odkaz:
https://doaj.org/article/44077365a8024a5c921a86b38dfeb99c
Autor:
Jungmin Lee, Juhyung Kim, Hee Jeong Cho, Dong Won Baek, Ji Yeon Ham, Soon Hee Chang, Sang Kyun Sohn, Young Rok Do, Joon Ho Moon
Publikováno v:
HemaSphere, Vol 7, p e657279e (2023)
Externí odkaz:
https://doaj.org/article/bbe62152956245f8b57662d1cdf67d04
Publikováno v:
HemaSphere, Vol 7, p e12315c1 (2023)
Externí odkaz:
https://doaj.org/article/eb8b0244ca1741c991733e97a25707fc
Autor:
Hee Jeong Cho, Sung-Hoon Jung, Jae-Cheol Jo, Yoo Jin Lee, Sang Eun Yoon, Sung-Soo Park, Do Young Kim, Ho-Jin Shin, Yeung-Chul Mun, Jun Ho Yi, Hyo Jung Kim, Da Jung Kim, Ho Sup Lee, Sung Hwa Bae, Chae Moon Hong, Shin Young Jeong, Jung-Joon Min, Sang Kyun Sohn, Chang-Ki Min, Kihyun Kim, Je-Jung Lee, Joon Ho Moon, The Korean Multiple Myeloma Working Party
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 12, Pp 1-8 (2021)
Abstract In multiple myeloma (MM), a high number of focal lesions (FL) detected using positron emission tomography/computed tomography (PET/CT) was found to be associated with adverse prognosis. To design a new risk stratification system that combine
Externí odkaz:
https://doaj.org/article/0960ae35758a464c82ae284b692a6988
Autor:
Dong Won Baek, Hee Jeong Cho, Ju-Hyung Kim, Jae Sook Ahn, Hyeoung-Joon Kim, Sung Nam Lim, Jun Won Cheong, Sung-Yong Kim, Ho Sup Lee, Jong Ho Won, Ho-Young Yhim, Sang Kyun Sohn, Joon Ho Moon
Publikováno v:
Cell Transplantation, Vol 31 (2022)
In this multicenter phase II study, we evaluated the safety and efficacy of imatinib in patients with steroid-resistant chronic graft-versus-host disease (cGVHD) and evaluated the quality of life (QOL) of the enrolled patients using the Short Form 36
Externí odkaz:
https://doaj.org/article/076fcd1f669d40b896741f1495d72e27
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 11, p 9437 (2023)
Non-small cell lung cancer (NSCLC) is a fatal malignant tumor with a high mortality rate. Cancer stem cells (CSCs) play pivotal roles in tumor initiation and progression, treatment resistance, and NSCLC recurrence. Therefore, the development of novel
Externí odkaz:
https://doaj.org/article/2b3e6fb3a16742c8a88bc7d43f3f6ab9